Cure Alzheimer's Fund Cure Alzheimer's Fund

Plasma Proteins, Sex and Alzheimer’s Disease: Proteome-Wide Analyses of the UK Biobank and Framingham Heart Study

2024

Women have been noted to be at the epicenter of the Alzheimer’s disease (AD) epidemic since they account for roughly two-thirds of AD patients in the US and the majority of caregivers. This proposal examines two large population studies, the UK Biobank and the Framingham Heart Study, to identify factors that may underlie gender and sex differences in AD risk and progression. 

Biomarkers/Diagnostics/Studies of Risk & Resilience Foundational P. Murali Doraiswamy

Funding to Date

$268,750

Focus

Biomarkers/Diagnostics/Studies of Risk & Resilience, Foundational

Researchers

P. Murali Doraiswamy, MBBS, FRCP

Related Content:


Plasma Proteins, Sex and Alzheimer’s Disease: Proteome-Wide Analyses of the UK Biobank and Framingham Heart Study P. Murali Doraiswamy 2024-12-16 Relationship Between Alzheimer’s Disease Risk Score and Outcomes of Mild Repetitive Neurotrauma Thomas McAllister Michael McCrea 2024-12-16 Alzheimer’s Disease PET Imaging of Nonfibrillar Amyloid Beta Aggregates Using Azapeptide (AZP) Tracer Sam Gandy Brigitte Guérin Shai Rahimipour William Lubell 2024-12-16 Midlife Autoantibody Profiles and the Risk of Late-Onset Alzheimer’s Disease in Women Yu Chen 2024-10-31 Bioinformatics Platform for Modeling Alzheimer’s Progression (MAP-AD Platform) Ali Ezzati 2024-09-16 Understanding Human Brain Resilience to Alzheimer’s Pathology Teresa Gomez-Isla 2024-08-19 Utility of Blood-Based Markers for Predicting Amyloid-Related Imaging Abnormalities and Their Course in Mild Cognitive Impairment and Alzheimer’s Disease Subjects Undergoing Routine Clinical Treatment with Amyloid-Directed Antibodies P. Murali Doraiswamy 2024-01-12 Characterization of the Longitudinal Trajectories of the Synaptic Blood Marker Beta-Synuclein during Alzheimer’s Disease Pathogenesis and Improvement of the Measurement Procedure Patrick Oeckl Markus Otto 2023-09-19